GlassScriptPhysician profile
Harit V Desai
NPI 1528393006
$16,980.36
in general payments reported to CMS, 2019-2025
44 companies · $3,207 in 2025
The $3,207 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,365 · 2020: $871 · 2021: $1,256 · 2022: $1,944 · 2023: $2,816 · 2024: $3,520 · 2025: $3,207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,734 · Travel and Lodging: $1,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,733.70 |
| Travel and Lodging | $1,810.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,043.62 | 2019-2025 | Mitraclip, Triclip, Cardiomems |
| Boston Scientific Corporation | $2,250.99 | 2019-2025 | Watchman Flx, Watchman Access System, Avvigo Guidance System |
| Edwards Lifesciences Corporation | $1,900.82 | 2019-2025 | Evoque, Pascal, Sapien 3 Ultra Resilia |
| Medtronic, INC. | $1,187.65 | 2021-2025 | Linq II, Onyx Frontier, Symplicity G3 |
| Abiomed | $585.71 | 2022-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $562.86 | 2019-2025 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $514.00 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $509.30 | 2019-2025 | |
| Scpharmaceuticals INC. | $495.90 | 2023-2025 | |
| Pfizer INC. | $411.12 | 2019-2025 | |
| Cvrx, INC. | $270.37 | 2022-2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $219.81 | 2023-2025 | Jardiance |
| Novo Nordisk INC | $213.49 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Merck Sharp & Dohme LLC | $186.64 | 2021-2023 | Verquvo, Steglatro |
| Kiniksa Pharmaceuticals, LTD. | $181.27 | 2022-2023 | Arcalyst |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $176.44 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $166.15 | 2019-2024 | Farxiga |
| Shockwave Medical, INC | $135.50 | 2021 | |
| Janssen Pharmaceuticals, INC | $89.49 | 2019-2024 | Xarelto |
| Ekos Corporation | $88.23 | 2019 | |
| Philips North America LLC | $70.50 | 2022-2025 | (9148) Ice 3d, Mcot |
| Inari Medical, INC. | $67.56 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Chiesi USA, INC. | $67.24 | 2023-2024 | Kengreal, Cleviprex |
| Lexicon Pharmaceuticals, INC. | $63.13 | 2023-2024 | Inpefa |
| Biotronik INC. | $49.73 | 2019-2024 | Biomonitor |
| Tactile Systems Technology INC | $45.31 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Actelion Pharmaceuticals US, INC. | $42.56 | 2023 | Opsumit, Uptravi |
| Kiniksa Pharmaceuticals International, Plc | $40.70 | 2024 | Arcalyst |
| Cordis US Corp. | $32.97 | 2021 | |
| Cardiovascular Systems INC. | $32.85 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.22 | 2025 | |
| Impulse Dynamics (USA) INC. | $29.25 | 2022 | |
| Teleflex LLC | $27.23 | 2019 | |
| Kestra Medical Technology Services, INC. | $22.78 | 2023 | Assure Wcd |
| Irhythm Technologies, INC. | $22.64 | 2022 | |
| Cagent Vascular INC | $20.47 | 2024 | Serrantor |
| Heartflow, INC. | $18.89 | 2023 | Ffrct |
| Inspire Medical Systems, INC. | $18.51 | 2025 | Inspire |
| Lilly USA, LLC | $17.16 | 2022 | |
| Glaxosmithkline, LLC. | $16.64 | 2025 | Shingrix |
| Angiodynamics, INC. | $16.61 | 2022 | |
| Becton, Dickinson and Company | $15.41 | 2024 | Crosser Iq |
| Baxter Healthcare | $14.06 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Itamar Medical INC | $8.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harit Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.